Market Overview:
The global CRISPR/Cas9 market is expected to reach USD 7,898.5 million by 2030 from USD 2,362.7 million in 2018, at a CAGR of 18.4%. The growth of the CRISPR/Cas9 market is mainly driven by the increasing demand for genome editing and genetic engineering applications, rising investments in CRISPR technology-based research and development activities, and growing number of patent filings for CRISPR technology. However, the high cost associated with R&D activities and lack of skilled professionals are restraining the growth of this market to some extent. On the basis of type, the global CRISPR/Cas9 market is segmented into genome editing tools (gene scissors), genetic engineering tools (cloning vectors), gRNA database/gene library services (online databases that store information on all known or predicted genes), CRISPR plasmids (vector systems used for gene delivery into cells), human stem cells (cells that can develop into any type of cell in an organism), genetically modified organisms/crops (organisms or crops whose genes have been altered using biotechnology techniques) and cell line engineering products & services. The genome editing tools segment is expected to account for the largest share of this market in 2018.
Product Definition:
CRISPR/Cas9 is a gene editing technology that enables scientists to make specific changes to the DNA of a living organism. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, while Cas9 is an enzyme that acts as the "scissors" to cut DNA. CRISPR/Cas9 can be used for many purposes, including correcting genetic defects, treating diseases, or increasing the efficiency of crops.
Genome Editing:
Genome editing is the process of changing an organism's genome using genetic engineering. It is also known as gene drive or CRISPR (CRISPR-Cas9). The technology was developed in 2012 by a team of researchers at the University of California, Berkeley. Since then, it has been rapidly gaining popularity and being used in various applications such as medical research & biotechnology and agriculture among others.
Genetic Engineering:
Genetic engineering is the process of modifying, changing, or correcting the genetic material (DNA & RNA) of living organisms. It is also known as gene therapy or genome editing. Genetic engineering has been widely used in plant and animal breeding to produce improved crops and livestock animals with fewer disease symptoms. However, it has recently gained immense popularity in the field of medical sciences due to its application in treating incurable diseases such as HIV/AIDS, cancer cells, etc.
Application Insights:
The biotechnology companies segment dominated the global market in terms of revenue in 2017. This is due to the rising number of research collaborations and investments by these companies for developing new therapies using CRISPR/Cas9 technology. For instance, in January 2018, Intellia Therapeutics, a leader in genetic engineering tools for editing genomes announced a collaboration with Nanfang Zhou Medical College of China University of Hong Kong to develop novel cancer treatments using CRISPR-Cas9 system. Similarly, In November 2017,Editas Medicine Inc collaborated with The Institute Of Cancer Research (ICR) and UCL (University College London) to accelerate development of genome editing tools for cancer treatment through an extensive R&D program supported by funding from the National Cancer Center Japan (NCC).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2016. This can be attributed to the presence of a large number of CRISPR/Cas9 providers and users, increased funding for genome editing research, and high adoption rate for advanced technologies across this region. Moreover, growing focus on drug discovery using cells derived from patients with specific diseases is expected to fuel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing investments by governments as well as private entities in genomics & biotechnology sectors. In addition, rising awareness about genomic medicine among people will drive regional demand further.
In addition it has been observed that countries like China are at forefront when it comes to adopting emerging technologies such as CRISPR technology which has led them being a dominant force within Asia Pacific region.
Growth Factors:
- Increasing demand for CRISPR/Cas9-based therapeutics: The increasing demand for CRISPR/Cas9-based therapeutics is one of the major growth drivers for the CRISPR/Cas9 market. This is because of the advantages offered by this technology over other gene editing technologies.
- Rising investment in R&D activities: The rising investment in R&D activities by biotechnology and pharmaceutical companies is another major growth driver for the CRISPR/Cas9 market. This is because of the potential applications of this technology in various therapeutic areas.
- Growing number of collaborations and partnerships: The growing number of collaborations and partnerships between biotechnology and pharmaceutical companies is another key factor driving the growth of the CRISPR/Cas9 market. This is because it helps to speed up product development and commercialization efforts.
- Technological advancements: The technological advancements that are taking place in this field are also helping to drive the growth of this market significantly. For instance, new methods such as base editing are being developed which offer better accuracy than traditional CRISPR methods thereby expanding its application potentialities further into new therapeutic areas such as cancer treatment, etcetera . 5) Emergence Of New Applications In Various Therapeutic Areas: Another key factor that is aiding in propellingthegrowthoftheCRISPRAcasamarketistheemergenceofnewapplicationsinvarioustherape
Scope Of The Report
Report Attributes
Report Details
Report Title
CRISPR/Cas9 Market Research Report
By Type
Genome Editing, Genetic Engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering
By Application
Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes
By Companies
Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, Agilent Technologies, Cellecta, GenScript, GeneCopoeia, Synthego
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global CRISPR/Cas9 Market Report Segments:
The global CRISPR/Cas9 market is segmented on the basis of:
Types
Genome Editing, Genetic Engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Caribou Biosciences
- Integrated DNA Technologies(IDT)
- CRISPR Therapeutics
- Merck
- Mirus Bio
- Editas Medicine
- Takara Bio
- Thermo Fisher Scientific
- Horizon Discovery Group
- Intellia Therapeutics
- Agilent Technologies
- Cellecta
- GenScript
- GeneCopoeia
- Synthego
Highlights of The CRISPR/Cas9 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Genome Editing
- Genetic Engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- By Application:
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the CRISPR/Cas9 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CRISPR/Cas9 is a gene editing tool that can be used to modify the DNA of cells. It was developed in the early 2000s and is now widely used in research and medicine. CRISPR/Cas9 can be used to target specific pieces of DNA, making it a powerful tool for genetic engineering.
Some of the major players in the crispr/cas9 market are Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, Agilent Technologies, Cellecta, GenScript, GeneCopoeia, Synthego.
The crispr/cas9 market is expected to grow at a compound annual growth rate of 18.4%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 CRISPR/Cas9 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 CRISPR/Cas9 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 CRISPR/Cas9 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the CRISPR/Cas9 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global CRISPR/Cas9 Market Size & Forecast, 2020-2028
4.5.1 CRISPR/Cas9 Market Size and Y-o-Y Growth
4.5.2 CRISPR/Cas9 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Genome Editing
5.2.2 Genetic Engineering
5.2.3 gRNA Database/Gene Librar
5.2.4 CRISPR Plasmid
5.2.5 Human Stem Cells
5.2.6 Genetically Modified Organisms/Crops
5.2.7 Cell Line Engineering
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Biotechnology Companies
6.2.2 Pharmaceutical Companies
6.2.3 Academic Institutes
6.2.4 Research and Development Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global CRISPR/Cas9 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 CRISPR/Cas9 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Genome Editing
9.6.2 Genetic Engineering
9.6.3 gRNA Database/Gene Librar
9.6.4 CRISPR Plasmid
9.6.5 Human Stem Cells
9.6.6 Genetically Modified Organisms/Crops
9.6.7 Cell Line Engineering
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Biotechnology Companies
9.10.2 Pharmaceutical Companies
9.10.3 Academic Institutes
9.10.4 Research and Development Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Genome Editing
10.6.2 Genetic Engineering
10.6.3 gRNA Database/Gene Librar
10.6.4 CRISPR Plasmid
10.6.5 Human Stem Cells
10.6.6 Genetically Modified Organisms/Crops
10.6.7 Cell Line Engineering
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Biotechnology Companies
10.10.2 Pharmaceutical Companies
10.10.3 Academic Institutes
10.10.4 Research and Development Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Genome Editing
11.6.2 Genetic Engineering
11.6.3 gRNA Database/Gene Librar
11.6.4 CRISPR Plasmid
11.6.5 Human Stem Cells
11.6.6 Genetically Modified Organisms/Crops
11.6.7 Cell Line Engineering
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Biotechnology Companies
11.10.2 Pharmaceutical Companies
11.10.3 Academic Institutes
11.10.4 Research and Development Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Genome Editing
12.6.2 Genetic Engineering
12.6.3 gRNA Database/Gene Librar
12.6.4 CRISPR Plasmid
12.6.5 Human Stem Cells
12.6.6 Genetically Modified Organisms/Crops
12.6.7 Cell Line Engineering
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Biotechnology Companies
12.10.2 Pharmaceutical Companies
12.10.3 Academic Institutes
12.10.4 Research and Development Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Genome Editing
13.6.2 Genetic Engineering
13.6.3 gRNA Database/Gene Librar
13.6.4 CRISPR Plasmid
13.6.5 Human Stem Cells
13.6.6 Genetically Modified Organisms/Crops
13.6.7 Cell Line Engineering
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Biotechnology Companies
13.10.2 Pharmaceutical Companies
13.10.3 Academic Institutes
13.10.4 Research and Development Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 CRISPR/Cas9 Market: Competitive Dashboard
14.2 Global CRISPR/Cas9 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Caribou Biosciences
14.3.2 Integrated DNA Technologies(IDT)
14.3.3 CRISPR Therapeutics
14.3.4 Merck
14.3.5 Mirus Bio
14.3.6 Editas Medicine
14.3.7 Takara Bio
14.3.8 Thermo Fisher Scientific
14.3.9 Horizon Discovery Group
14.3.10 Intellia Therapeutics
14.3.11 Agilent Technologies
14.3.12 Cellecta
14.3.13 GenScript
14.3.14 GeneCopoeia
14.3.15 Synthego
